Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Overall Study	STARTED	Fluzone HD + mRNA-1345 Followed by Placebo	950
Overall Study	STARTED	Fluzone HD + Placebo Followed by mRNA-1345	950
Overall Study	Received Day 1 Injection	Fluzone HD + mRNA-1345 Followed by Placebo	946
Overall Study	Received Day 1 Injection	Fluzone HD + Placebo Followed by mRNA-1345	947
Overall Study	Received Day 22 Injection	Fluzone HD + mRNA-1345 Followed by Placebo	919
Overall Study	Received Day 22 Injection	Fluzone HD + Placebo Followed by mRNA-1345	911
Overall Study	Safety Set	Fluzone HD + mRNA-1345 Followed by Placebo	947
Overall Study	Safety Set	Fluzone HD + Placebo Followed by mRNA-1345	946
Overall Study	COMPLETED	Fluzone HD + mRNA-1345 Followed by Placebo	914
Overall Study	COMPLETED	Fluzone HD + Placebo Followed by mRNA-1345	909
Overall Study	NOT COMPLETED	Fluzone HD + mRNA-1345 Followed by Placebo	36
Overall Study	NOT COMPLETED	Fluzone HD + Placebo Followed by mRNA-1345	41

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT06060457/flow